- Home
- LXRX vs AMRN Comparison
LXRX vs AMRN Comparison
Compare LXRX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- AMRN
- Stock Information
- Founded
- LXRX 1995
- AMRN 1989
- Country
- LXRX United States
- AMRN Ireland
- Employees
- LXRX N/A
- AMRN N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- LXRX Health Care
- AMRN Health Care
- Exchange
- LXRX Nasdaq
- AMRN Nasdaq
- Market Cap
- LXRX 228.8M
- AMRN 216.0M
- IPO Year
- LXRX 2000
- AMRN 1993
- Fundamental
- Price
- LXRX $1.08
- AMRN $16.90
- Analyst Decision
- LXRX Buy
- AMRN Strong Sell
- Analyst Count
- LXRX 4
- AMRN 1
- Target Price
- LXRX $3.67
- AMRN $12.00
- AVG Volume (30 Days)
- LXRX 5.0M
- AMRN 171.7K
- Earning Date
- LXRX 07-31-2025
- AMRN 07-30-2025
- Dividend Yield
- LXRX N/A
- AMRN N/A
- EPS Growth
- LXRX N/A
- AMRN N/A
- EPS
- LXRX N/A
- AMRN N/A
- Revenue
- LXRX $31,213,000.00
- AMRN $214,112,000.00
- Revenue This Year
- LXRX N/A
- AMRN N/A
- Revenue Next Year
- LXRX N/A
- AMRN N/A
- P/E Ratio
- LXRX N/A
- AMRN N/A
- Revenue Growth
- LXRX 1251.21
- AMRN N/A
- 52 Week Low
- LXRX $0.28
- AMRN $7.08
- 52 Week High
- LXRX $2.45
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- LXRX 66.94
- AMRN 71.53
- Support Level
- LXRX $0.84
- AMRN $16.12
- Resistance Level
- LXRX $1.19
- AMRN $17.49
- Average True Range (ATR)
- LXRX 0.09
- AMRN 0.96
- MACD
- LXRX 0.02
- AMRN 0.05
- Stochastic Oscillator
- LXRX 76.60
- AMRN 90.37
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.